Prednisolone 20 mg Kela 20 mg Tablet
Prednisolone 20 mg Kela 20 mg Tablet
Authorised
- Prednisolone
Product identification
Medicine name:
Prednisolone 20 mg Kela 20 mg Tablet
Prednisolone 20 mg Kela 20 mg Comprimé
Prednisolone 20 mg Kela 20 mg Tablette
Active substance:
- Prednisolone
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Prednisolone20.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD07BA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Prednisolone 20 mg Kela 100 Tablets in 10 blisters with 10 tablets
- Prednisolone 20 mg Kela 50 Tablets in 5 blisters with 10 tablets
- Prednisolone 20 mg Kela 30 Tablets in 3 blisters with 10 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Marketing authorisation holder:
- KELA Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
- KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V329095
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?:
